222 related articles for article (PubMed ID: 33965858)
21. Repressing of NHERF1 inhibits liver cancer progression by promoting the production of ROS.
Sun J; Li P; Yang J
Biochem Biophys Res Commun; 2019 Jan; 509(1):8-15. PubMed ID: 30581004
[TBL] [Abstract][Full Text] [Related]
22. Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance.
Vaquero J; Nguyen Ho-Bouldoires TH; Clapéron A; Fouassier L
Oncogene; 2017 Jun; 36(22):3067-3079. PubMed ID: 28068322
[TBL] [Abstract][Full Text] [Related]
23. Na+/H+ exchanger regulatory factor 1 overexpression-dependent increase of cytoskeleton organization is fundamental in the rescue of F508del cystic fibrosis transmembrane conductance regulator in human airway CFBE41o- cells.
Favia M; Guerra L; Fanelli T; Cardone RA; Monterisi S; Di Sole F; Castellani S; Chen M; Seidler U; Reshkin SJ; Conese M; Casavola V
Mol Biol Cell; 2010 Jan; 21(1):73-86. PubMed ID: 19889841
[TBL] [Abstract][Full Text] [Related]
24. A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression.
Yang X; Du G; Yu Z; Si Y; Martin TA; He J; Cheng S; Jiang WG
Anticancer Res; 2017 Jan; 37(1):67-73. PubMed ID: 28011475
[TBL] [Abstract][Full Text] [Related]
25. Prognostic and therapeutic implications of NHERF1 expression and regulation in colorectal cancer.
Leiphrakpam PD; Lazenby AJ; Chowdhury S; Smith LM; Mathiesen M; Brattain MG; Wang J; Black JD; Are C
J Surg Oncol; 2020 Mar; 121(3):547-560. PubMed ID: 31867736
[TBL] [Abstract][Full Text] [Related]
26. Na+-H+ exchanger regulatory factor 1 is a PDZ scaffold for the astroglial glutamate transporter GLAST.
Lee A; Rayfield A; Hryciw DH; Ma TA; Wang D; Pow D; Broer S; Yun C; Poronnik P
Glia; 2007 Jan; 55(2):119-29. PubMed ID: 17048262
[TBL] [Abstract][Full Text] [Related]
27. NHERF1/EBP50 controls lactation by establishing basal membrane polarity complexes with prolactin receptor.
Morales FC; Hayashi Y; van Pelt CS; Georgescu MM
Cell Death Dis; 2012 Sep; 3(9):e391. PubMed ID: 22992649
[TBL] [Abstract][Full Text] [Related]
28. NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia.
Georgescu MM; Gagea M; Cote G
Neoplasia; 2016 Aug; 18(8):512-23. PubMed ID: 27566107
[TBL] [Abstract][Full Text] [Related]
29. NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma.
Saponaro C; Vagheggini A; Scarpi E; Centonze M; Catacchio I; Popescu O; Pastena MI; Giotta F; Silvestris N; Mangia A
J Exp Clin Cancer Res; 2018 May; 37(1):96. PubMed ID: 29716631
[TBL] [Abstract][Full Text] [Related]
30. Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer.
Song J; Bai J; Yang W; Gabrielson EW; Chan DW; Zhang Z
Histopathology; 2007 Jul; 51(1):40-53. PubMed ID: 17593079
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical analysis of ezrin-radixin-moesin-binding phosphoprotein 50 in prostatic adenocarcinoma.
Bartholow TL; Becich MJ; Chandran UR; Parwani AV
BMC Urol; 2011 Jun; 11():12. PubMed ID: 21672215
[TBL] [Abstract][Full Text] [Related]
32. Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis.
Malfettone A; Saponaro C; Paradiso A; Simone G; Mangia A
BMC Cancer; 2012 Mar; 12():106. PubMed ID: 22439624
[TBL] [Abstract][Full Text] [Related]
33. Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation.
Molina JR; Morales FC; Hayashi Y; Aldape KD; Georgescu MM
Cancer Res; 2010 Sep; 70(17):6697-703. PubMed ID: 20736378
[TBL] [Abstract][Full Text] [Related]
34. A Comparative Immunohistochemical Study of Epithelial Membrane Antigen and NHERF1/EBP50 in the Diagnosis of Ependymomas.
Nambirajan A; Sharma MC; Rajeshwari M; Kakkar A; Suri V; Sarkar C
Appl Immunohistochem Mol Morphol; 2018 Jan; 26(1):71-78. PubMed ID: 27753657
[TBL] [Abstract][Full Text] [Related]
35. Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions.
Lin YY; Hsu YH; Huang HY; Shann YJ; Huang CY; Wei SC; Chen CL; Jou TS
J Clin Invest; 2012 May; 122(5):1881-94. PubMed ID: 22466651
[TBL] [Abstract][Full Text] [Related]
36. Alterations in the proteome of the NHERF1 knockout mouse jejunal brush border membrane vesicles.
Donowitz M; Singh S; Singh P; Salahuddin FF; Chen Y; Chakraborty M; Murtazina R; Gucek M; Cole RN; Zachos NC; Kovbasnjuk O; Broere N; Smalley-Freed WG; Reynolds AB; Hubbard AL; Seidler U; Weinman E; de Jonge HR; Hogema BM; Li X
Physiol Genomics; 2010 Nov; 42A(3):200-10. PubMed ID: 20736413
[TBL] [Abstract][Full Text] [Related]
37. Sip1, the Drosophila orthologue of EBP50/NHERF1, functions with the sterile 20 family kinase Slik to regulate Moesin activity.
Hughes SC; Formstecher E; Fehon RG
J Cell Sci; 2010 Apr; 123(Pt 7):1099-107. PubMed ID: 20215404
[TBL] [Abstract][Full Text] [Related]
38. The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker.
Gokden N; Gokden M; Phan DC; McKenney JK
Am J Surg Pathol; 2008 Oct; 32(10):1462-7. PubMed ID: 18685487
[TBL] [Abstract][Full Text] [Related]
39. β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients.
Schirosi L; Mazzotta A; Opinto G; Pinto R; Graziano G; Tommasi S; Fucci L; Simone G; Mangia A
Oncotarget; 2016 Oct; 7(42):67841-67850. PubMed ID: 27765918
[TBL] [Abstract][Full Text] [Related]
40. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S
Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
